Our Core
We aspire to make a lasting impact for patients with cardiac diseases
Cardior Pharmaceuticals is a leading clinical-stage biopharmaceutical company pioneering the discovery and development of RNA-based therapeutics designed to prevent, repair and reverse diseases of the heart. Cardior’s therapeutic approach uses distinctive non-coding RNAs as an innovative platform for addressing the root causes of cardiac dysfunctions. The company aspires to bring transformative therapeutics and diagnostics to patients and thereby make a lasting impact on the treatment of cardiac diseases worldwide.
Management Team



Board









Scientific Advisory Board








Investors
Cardior is supported by a range of prestigious life science investors.









Partners
We have established successful relationships with renowned academic partners and are always looking for new collaboration opportunities to further advance our innovative therapy approach.